Stocktoria

NEOGEN CORP NEOG

Nasdaq · stock · In Vitro & In Vivo Diagnostic Substances · website · IPO 1989-08-23 · LEI

NEOGEN CORP financials (annual)

Revenue
$361.6M $397.9M $414.2M $418.2M $468.5M $527.2M $822.4M $924.2M $894.7M $870.4M 2017201820192020202120222023202420252026
Net income
$43.8M $63.1M $60.2M $59.5M $60.9M $48.3M -$22.9M -$9.4M -$1.09B -$7.9M 2017201820192020202120222023202420252026
Free cash flow
2017201820192020202120222023202420252026

Bars are annual figures from 2017 to 2026; red bars are negative (a loss or cash outflow).

MetricFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue$870.4M$894.7M$924.2M$822.4M$527.2M$468.5M$418.2M$414.2M$397.9M$361.6M
Gross profit$408.5M$421.4M$463.9M$406.0M$243.0M$215.1M$196.3M$191.9M$186.3M$168.9M
R&D expense$18.4M$21.1M$22.5M$26.0M$17.0M$16.2M$14.8M$12.8M$10.9M$10.4M
Operating income-$21.6M-$1.1B$58.6M$37.5M$58.6M$74.2M$67.5M$68.1M$70.2M$64.9M
Interest expense$24.1M$38.1M$42.2M$27.3M
Income tax-$1.1M-$41.1M-$4.9M$828,000$11.9M$14.4M$12.8M$12.8M$10.2M$22.7M
Net income-$7.9M-$1.1B-$9.4M-$22.9M$48.3M$60.9M$59.5M$60.2M$63.1M$43.8M
EPS (diluted)$-0.04$-5.03$-0.04$-0.12$0.23$0.28$0.28$0.28$0.30$0.21
Operating cash flow$83.2M$58.2M$35.3M$41.0M$68.0M$81.1M$85.9M$63.8M$69.1M$60.3M
Cash & equivalents$185.5M$129.0M$170.6M$163.2M$44.5M$75.6M$66.3M$41.7M$83.1M$77.6M
Inventory$144.3M$190.8M$189.3M$133.8M$122.3M$100.7M$95.1M$86.0M$76.0M$73.1M
Total assets$3.3B$3.4B$4.5B$4.6B$992.9M$920.2M$797.2M$695.7M$618.0M$528.4M
Total liabilities$1.3B$1.4B$1.4B$1.4B$105.6M$79.8M$72.0M$57.8M$57.8M$56.7M
Shareholders' equity$2.1B$2.1B$3.1B$3.1B$887.4M$840.4M$725.2M$637.9M$560.2M$471.8M

Growth · year-over-year · Revenue CAGR 10.3%

MetricFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue growth-2.7%-3.2%+12.4%+56.0%+12.5%+12.0%+1.0%+4.1%+10.0%+12.5%
Net income growth-147.3%-20.7%+2.4%-1.2%-4.7%+44.2%+19.8%
EPS growth-153.3%-21.1%+1.8%-1.8%-5.8%+40.7%+19.4%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-05-31. Facts plus Stocktoria's own computed scores — not investment advice.